Key result
Rocuronium reversed by sugammadex significantly reduced the time to 90% recovery of neuromuscular blockade compared to mivacurium (23.83 vs 28.32 minutes, p=0.009) in patients undergoing laryngeal microsurgery.
Why the study?
The introduction of sugammadex created new opportunities for rapid reversal of steroid relaxants, prompting a comparison of muscle relaxation with mivacurium versus rocuronium in laryngeal microsurgery.
Does rocuronium with sugammadex reversal improve surgical conditions and neuromuscular blockade recovery compared to mivacurium in patients undergoing laryngeal microsurgery?
RCT (n=65)
randomly divided
Does rocuronium with sugammadex reversal improve surgical conditions and neuromuscular blockade recovery compared to mivacurium in patients undergoing laryngeal microsurgery?
Absolute Event Rate: 23.83% vs 28.32%
p-value: p=0.009
Rocuronium reversed by sugammadex provides better surgical conditions and faster recovery of neuromuscular blockade compared to mivacurium in laryngeal microsurgery.
May warrant rocuronium/sugammadex preference in laryngeal microsurgery; extends RCT evidence on optimized neuromuscular recovery.
Introduction: The introduction of sugammadex has created new opportunities for a quick reversal of relaxation caused by steroid relaxants. Aim: The objective of this study was to compare relaxation of striated muscles in laryngeal microsurgery depending on the applied agent: mivacurium or rocuronium. Material and methods: 65 low-risk surgery patients were randomly divided into two groups: MIV (n = 32) and ESM (n = 33) before the scheduled larynx microsurgery. The MIV group used mivacurium to relax the muscles, the ESM group used rocuronium.The following parameters were monitored: pulse rate, arterial blood pressure, arterial blood saturation, ventilation parameters according to the conventional standards and the depth and rate of neuromuscullar blockade (NMB) reversal. The demand for anesthetics and analgesics used during the anesthesia and the frequency of complication occurrence were evaluated. Results and discussion: There were no differences under intubation conditions. The conditions of the operation assessed by its operator were better in the ESM group. The time of the operation was similar in the two groups. The acting time of sugammadex in the ESM group was on average 1 minute. The ESM group reached train-of-four ratio (TOFR) of 0.9 (90% recovery of NMB) far more quickly than the MIV group. There was no statistical difference in side effects. Conclusions: It seems to be reasonable to replace mivacurium with rocuronium and reverse its action by means of sugammadex in patients with a positive family history of allergy and anaesthetized for short-term operations or operations of unpredictable duration.
No takes yet. Share an insight, caveat, or question.
Glinka et al. (2021) conducted an RCT in Laryngeal microsurgery (n=65). Rocuronium and sugammadex vs. Mivacurium was evaluated on Time to 90% recovery of neuromuscular blockade (TOFR = 0.9) in minutes (p=0.009). Rocuronium reversed by sugammadex significantly reduced the time to 90% recovery of neuromuscular blockade compared to mivacurium (23.83 vs 28.32 minutes, p=0.009) in patients undergoing laryngeal microsurgery.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: